Reform at Commission could change device oversight
This article was originally published in Clinica
Changes at the European Commission are likely to affect the oversight of medical device regulation in Europe. This could follow the formal approval on September 15 by the European Parliament of the new Commission and a raft of new reform recommendations put forward by a committee of independent experts.
You may also be interested in...
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.